Effects of lactoferrin on the differentiation of pluripotent mesenchymal cells

Cell Biology International

Volumn 33, Issue 3, 2009, Pages 283-289

  Yagi, Motohiko ^a   Suzuki, Naoto ^a   Takayama, Tadahiro ^a   Arisue, Masatoshi ^a   Kodama, Takuya ^a   Yoda, Yasushi ^a   Otsuka, Kichibee ^a   Ito, Koichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

C2C12 cells; Lactoferrin; Osteogenesis; Runx2

Indexed keywords

ALKALINE PHOSPHATASE; DESMIN; LACTOFERRIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEGALIN; MESSENGER RNA; MYOD PROTEIN; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVITY; MESENCHYMAL STEM CELL; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; LACTOFERRIN; LDL-RECEPTOR RELATED PROTEIN 1; LDL-RECEPTOR RELATED PROTEIN 2; MESENCHYMAL STEM CELLS; MICE; MYOD PROTEIN; PLURIPOTENT STEM CELLS; PPAR GAMMA; SOX9 TRANSCRIPTION FACTOR;

EID: 61349136891     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.11.013     Document Type: Article

References (37)

1. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16 (2002) 2813-2828
2. Anderson H.C. Mechanism of mineral formation in bone. Lab Invest 60 (1989) 320-330
3. Aubin J.E., Liu F., Malaval L., and Gupta A.K. Osteoblast and chondroblast differentiation. Bone 17 (1995) 77S-83S
4. Aubin J.E. Advances in the osteoblast lineage. Biochem Cell Biol 76 (1998) 899-910
5. Baveye S., Elass E., Mazurier J., Spik G., and Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37 (1999) 281-286
6. Bi B.Y., Lefebvre A.M., Duś D., Spik G., and Mazurier J. Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line. Arch Immunol Ther Exp 45 (1997) 315-320
7. Bi W., Deng J.M., Zhang Z., Behringer R.R., and de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet 22 (1999) 85-89
8. Blau H.M., Chiu C.P., and Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32 (1983) 1171-1180
9. Caccavo D., Sebastiani G.D., Di Monaco C., Guido F., Galeazzi M., Ferri G.M., et al. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis. Int J Clin Lab Res 29 (1999) 30-35
10. Cornish J., Callon K.E., Naot D., Palmano K.P., Banovic T., Bava U., et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145 (2004) 4366-4374
11. Cornish J. Lactoferrin promotes bone growth. Biometals 17 (2004) 331-335
12. Elass E., Masson M., Mazurier J., and Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70 (2002) 1860-1866
13. Frydecka I., Zimecki M., Bocko D., Kosmaczewska A., Teodorowska R., Ciszak L., et al. Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res 22 (2002) 1897-1901
14. Geoffroy V., Kneissel M., Fournier B., Boyde A., and Matthias P. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22 (2002) 6222-6233
15. Gerstenfeld L.C., Chipman S.D., Glowacki J., and Lian J.B. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122 (1987) 49-60
16. Guillén C., McInnes I.B., Vaughan D.M., Kommajosyula S., Van Berkel P.H., Leung B.P., et al. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J Immunol 168 (2002) 3950-3957
17. Hammarström L., Heijl L., and Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24 (1997) 669-677
18. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24 (1997) 693-696
19. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. T argeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
21. Lekic P.C., Pender N., and McCulloch C.A. Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues?. Crit Rev Oral Biol Med 8 (1997) 253-268
22. Li Y., Cam J., and Bu G. Low-density lipoprotein receptor family: endocytosis and signal transduction. Mol Neurobiol 23 (2001) 53-67
23. Liu N.K., and Xu X.M. Beta-tubulin is a more suitable inyernal control than beta-actin in western blot analysis of spinal cord tissue after traumatic injuly. J Neurotrauma 23 (2006) 1794-1801
24. Liu W., Toyosawa S., Furuichi T., Kanatani N., Yoshida C., Liu Y., et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155 (2001) 157-166
25. Lönnerdal B., and Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15 (1995) 93-110
26. McCulloch C.A. Progenitor cell populations in the periodontal ligament of mice. Anat Rec 211 (1985) 258-262
27. Metz-Boutigue M.H., Jollès J., Mazurier J., Schoentgen F., Legrand D., Spik G., et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 145 (1984) 659-676
28. Naot D., Grey A., Reid I.R., and Cornish J. Lactoferrin -a novel bone growth factor. Clin Med Res 3 (2005) 93-101
29. Olson E.N. MyoD family: a paradigm for development?. Genes Dev 4 (1990) 1454-1461
30. Phipps R.P., Borrello M.A., and Blieden T.M. Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res 32 (1997) 159-165
31. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531-543
32. Strickland D.K., Gonias S.L., and Argraves W.S. Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13 (2002) 66-74
33. Vash B., Phung N., Zein S., and DeCamp D. Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin. Blood 92 (1998) 3277-3285
34. Ward P.P., Mendoza-Meneses M., Mulac-Jericevic B., Cunningham G.A., Saucedo-Cardenas O., Teng C.T., et al. Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 140 (1999) 1852-1860
35. Weinberg E.D. Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 53 (2001) 1303-1310
36. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251 (1991) 761-766
37. Yamaguchi A. Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol 6 (1995) 165-173